# Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

> **NCT01298999** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 27 (actual)

## Conditions studied

- Barrett's Esophagus

## Interventions

- **DRUG:** YF476
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01298999
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298999, "Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01298999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*